Goldman expects IBM’s 2026 guidance to show stronger demand, higher EPS and $15B+ FCF amid the Confluent deal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback